Current Developments in Microvolt T-wave Alternans
Author Information
Author(s): Beata Sredniawa MD, Agata Musialik-Lydka MD, Jacek Kowalczyk MD, Zbigniew Kalarus PhD
Primary Institution: Silesian Medical School, Silesian Center for Heart Diseases
Hypothesis
Microvolt T-wave alternans (MTWA) can help identify patients who will and will not benefit from implantable cardioverter-defibrillator (ICD) therapy.
Conclusion
MTWA is a useful non-invasive test for predicting arrhythmic events and identifying patients at low risk for sudden cardiac death.
Supporting Evidence
- MTWA has a negative predictive value of 97.2%, indicating it can effectively identify low-risk patients.
- A meta-analysis showed a positive predictive value of 19.3% for arrhythmic events.
- The predictive value of MTWA varies significantly in different patient populations.
Takeaway
MTWA is a test that looks at tiny changes in heart signals to help doctors figure out who might have dangerous heart problems and who doesn't need a defibrillator.
Methodology
The review summarizes various studies on MTWA, including its predictive value for arrhythmic events and the methods used for its assessment.
Limitations
The predictive value of MTWA varies significantly across different patient populations, and the standardization of test criteria is still needed.
Participant Demographics
The studies included a wide range of subjects, including patients with congestive heart failure, ischemic heart disease, and healthy individuals.
Statistical Information
P-Value
3.77
Confidence Interval
95% CI 17.7% to 21.0%
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website